Prostate Tests - Lexington Diagnostic Center

Tests for Prostate cancer offered at LDC:

MRI with Dynamic Contrast Enhancement (DCE) and Computer Assisted Diagnosis (CAD)

ProstaScint® nuclear medicine scan with CT fusion

Nuclear Medicine bone scans

Ultrasound

CT Scans

X-Ray

Prostate MRI

Prostate MRI is an MRI of the pelvis with and without contrast using iCAD VividLook® software.

Multiparametric MRI with Dynamic Contrast Enhancement (DCE)

DCE MRI highlights and localizes prostate cancer.

DCE measures abnormal blood flow through leaky blood vessels that are present in cancer.

Colorized map indicates areas that are suspicious or abnormal, providing target for biopsy.

Does not require rectal probe.

Test is only 40 minutes.

MRI screening for prostate cancer.

By Dr. George Privett

Prostate PSA screenings key to cancer prevention; test still holds value despite recent studies

It's not surprising that there is confusion surrounding the prostate-specific antigen (PSA) blood test. Recommendations for when men should have it vary and results are often unclear.

Prostate DCE- MRI at LDC

Dynamic Contrast Enhanced MRI gives First Good Pictures of Prostate Cancer.

Lexington Diagnostic Center & OPEN MRI has acquired the capability of providing MRI of the prostate to demonstrate the presence and localization or the absence of the cancer. The test utilizes an MRI of the pelvis area with and without contrast enhancement using a surface coil and computer assisted diagnosis (CAD).

Measures abnormal blood flow through leaky blood vessels that are present in cancer.

Colorized map indicates areas in the prostate that are suspicious and abnormal.

The test takes about 40 minutes and does not require a rectal probe or difficult bowel preparation.

Images provide the ability to highlight and localize prostate cancer.

Allows urologists to target specific areas of the prostate for biopsy and increase chance for finding cancer if present.

Did you know?

Prostate cancer is the second most common cancer in men after skin cancer.

Prostate cancer is the second most common cause of cancer death in men after lung cancer.

There is a one in two chance that a man will develop prostate cancer.

Most cases of prostate cancer are detected by elevation of a blood test called Prostate Specific Antigen (PSA) and/or Digital Rectal Exam (DRE).

Statistics show that when the PSA is abnormal, only 12-20% of men will have a biopsy positive for cancer.

When the PSA is normal, 15% of men will still have cancer.

At least 20% of cancers are missed even when 10 to 30 random (blind) biopsies of the prostate are taken.

Visualizing cancer within the prostate has been difficult because the prostate is small and deep in the body.

ProstaScint®

Example on Left of CT scans of Prostate. Example on Right of Abnormal ProstaScint scans showing abnormal collection of the antigen.

Used to determine if prostate cancer has reoccurred.

ProstaScint® with CT fusion can provide information to urologists and oncologists to assist in the diagnosis and treatment of recurrent prostate cancer.

Lexington Diagnostic Center and OPEN MRI is the only facility in the Bluegrass area to provide this service and is only one of four facilities in Kentucky.

More information about Prostate Cancer can be found at:

The AdMeTech Foundation (www.admetech.org)

The Men's Health Network (www.menshealthnetwork.org)

Prostate Health Education Network (www.prostatehealthed.org)

Prostate Cancer Foundation (www.prostatecancerfoundation.org)

UsToo Prostate Cancer Ed. & Support (www.ustoo.org)